Oncology
Sarcoma
7
Pipeline Programs↗
14
Active Trials↗
7
Companies Involved↗
Sarcoma is an early-stage landscape with 7 programs across 7 companies. The most active players are Amgen, Avyxa, Eastern Cooperative Oncology Group. 5 programs are in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Phase 1
No programs
Phase 35
Approved
No programs
Analysis
Modality Breakdown
8programs
Small molecule338%
Protein / enzyme225%
Monoclonal antibody113%
Cell therapy113%
Vaccine113%
Modality classified for 89% of 9 pipeline programs.
Analysis
Trial Status
30
clinical trials
Completed11 · 37%
Active, not recruiting6 · 20%
Recruiting6 · 20%
Terminated3 · 10%
Not yet recruiting2 · 7%
Unknown status1 · 3%
Other1 · 3%
Clinical Trials
Trial Activity
30 trials
TVEC and Preop Radiation for Sarcoma (8 ml Dose)
Active, not recruiting·—·Phase 1/2·NCT04599062·8 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)